(6399) Angio Ifr
Payments companies reported to CMS as associated with (6399) Angio Ifr. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (6399) Angio Ifr, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (6399) Angio Ifr
These are the largest totals companies reported as associated with (6399) Angio Ifr. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Karim Al-Azizi | Plano, TX | Interventional Cardiology | $257.35 |
| Leroy Rabbani | New York, NY | Interventional Cardiology | $257.35 |
| Darshan Doshi | Boston, MA | Interventional Cardiology | $257.35 |
| Prasad Gunasekaran | Kansas City, KS | Interventional Cardiology | $257.35 |
| Luis Gruberg | East Setauket, NY | Interventional Cardiology | $257.35 |
| Rayji Tsutsui | Cleveland, OH | $167.93 | |
| Gregg Stone | New York, NY | Cardiovascular Disease | $167.93 |
| Tai Pham | Sacramento, CA | Internal Medicine | $130.00 |
| Garrett Wong | Sacramento, CA | Cardiovascular Disease | $129.99 |
| Paul Teirstein | La Jolla, CA | Interventional Cardiology | $121.40 |
Prescribed (6399) Angio Ifr?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.